

| Drug common name | CEP-32496 |
| INN | agerafenib |
| Description | Cep-32496 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target RAF proto-oncogene serine/threonine-protein kinase and serine/threonine-protein kinase B-raf. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC |
| PDB | — |
| CAS-ID | 1188910-76-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2029988 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 78I4VEX88N (ChemIDplus, GSRS) |